Remedee Labs
Redefining Lifewith chronic pain
France · $13.3M raised
- Business Model
- B2C
- Website
- remedeelabs.com
- Total Funding
- $13.3M
- Last Round
- $13.3M Series ADec 2022
- Rounds
- 1
About
Remedee Labs develops wearable endorphin-stimulating devices offering non-pharmaceutical, clinically validated chronic pain management solutions.
Summary
Remedee Labs is a Biotech company based in France. It has raised $13.3M in total across 1 round, most recently a $13.3M Series A round in Dec 2022. Investors include Generali France, Habert Dassault Finance and Bpifrance.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...